13F-HR filed by CHI Advisors LLC
CHI Advisors LLC filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-14, with 21 holding rows worth $499,513,000.
- Accession
- 0001085146-21-001643
- Filer
- CIK 1791468
- Filed
- 2021-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 21 entries on the cover page, a total value of $499,513,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $499,513,000 with VALUE read as thousands by filing date, 13F file number 028-19612. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 2,202,407 | $91,774,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 2,324,795 | $91,434,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 2,560,703 | $78,588,000 | thousands by filing date | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 2,874,032 | $52,480,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 4,051,972 | $29,417,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 1,771,786 | $24,663,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 400,468 | $24,649,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 814,756 | $23,017,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 1,515,148 | $22,136,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 927,264 | $18,360,000 | thousands by filing date | |
| FREELINE THERAPEUTICS HLDGS | 35655L107 | SPONSORED ADS | 1,384,743 | $17,033,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 858,027 | $11,901,000 | thousands by filing date | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 691,629 | $7,158,000 | thousands by filing date | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 679,132 | $2,092,000 | thousands by filing date | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 50,000 | $1,203,000 | thousands by filing date | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 174,169 | $1,038,000 | thousands by filing date | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 247,510 | $995,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 15,000 | $611,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 40,209 | $396,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 3,500 | $340,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 2,000 | $228,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-21-001643 | this filing | 2021-05-14 | acceptance time not in the bulk data set |